Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 2009-2016

  Shimizu, Kenichiro ^a   Yoshii, Yutaka ^a   Morozumi, Miyuki ^b   Chiba, Naoko ^b   Ubukata, Kimiko ^b   Uruga, Hironori ^c   Hanada, Shigeo ^c   Saito, Nayuta ^a   Kadota, Tsukasa ^a   Ito, Saburo ^a   Wakui, Hiroshi ^a   Takasaka, Naoki ^a   Minagawa, Shunsuke ^a   Kojima, Jun ^a   Hara, Hiromichi ^a   Numata, Takanori ^a   Kawaishi, Makoto ^a   Saito, Keisuke ^d   Araya, Jun ^a   Kaneko, Yumi ^a   Nakayama, Katsutoshi ^a   Kishi, Kazuma ^c   Kuwano, Kazuyoshi ^a   more..

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

COPD; Etiology; Exacerbation; Prolonged hospitalization; Real time PCR; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; IMMUNOASSAY; MALE; MYCOPLASMA PNEUMONIAE; NONHUMAN; NOSE SMEAR; PATHOGENESIS; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEROLOGY; SPUTUM ANALYSIS; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; VERY ELDERLY; VIRUS IDENTIFICATION; VIRUS INFECTION; COMPLICATION; DISEASE COURSE; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RESPIRATORY TRACT INFECTIONS; SPUTUM;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SPUTUM;

EID: 84942749772     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S82752     Document Type: Article

References (28)

1. Niewoehner DE. The impact of sever exacerbation on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med. 2006;119:38-45.
2. Sapey E, Stockley IRA. COPD exacerbations 2: aetiology. Thorax. 2006;61: 250-258.
3. Sethi S, Sethi R, Eschberger K, et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:356-361.
4. Mohab A, Chandra S, Agawal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15:536-542.
5. Hirschmann JV. Do bacteria cause exacerbations of COPD? Chest. 2000; 118:193-203.
6. Templeton KE, Scheltinga SA, van den Eeden WC, et al. Improved diagnosis of the etiology of community-acquired pneumonia in adults. Clin Infect Dis. 2005;41:345-351.
7. Lieberman D, Shimoni A, Shemer-Avni Y, et al. Respiratory viruses in adults with community-acquired pneumonia. Chest. 2010;138: 811-816.
8. De Serres G, Lampron N, La Forge J, et al. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol. 2009;46:129-133.
9. Hutchinson AF, Ghimire AK, Thompson MA, et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Resp Med. 2007;101:2472-2481.
10. Perotin JM, Dury S, Renois F, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. 2013;85:866-873.
11. Miravitilles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121:1449-1455.
12. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173:1114-1121.
13. Clark TW, Medina MJ, Batham S, et al. C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD. EurRespir J. 2015;45(1):76-86.
14. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. NHLBI/WHO Workshop Report. Claude Lenfant, MD: National Heart, Lung, and Blood Institute, 2011.
15. Morozumi M, Nakayama E, Iwata S, et al. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Infect Chemother. 2006;44:1440-1446.
16. Hamano-Hasegawa K, Morozumi M, Nakayama E, et al. Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother. 2008;14: 424-432.
17. Okada T, Morozumi M, Sakata H, et al. A practical approach estimating etiologic agents using real-time PCR in pediatric inpatients with community-acquired pneumonia. J Infect Chemother. 2012;18: 832-840.
18. Murray PR, Baron EJ, Jorgensen JH, et al. Manual of Clinical Microbiology. 9th ed. Washington, DC: American Society of Microbiology; 2007.
19. Theerthakarai R, El-Halees W, Ismail M, et al. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest. 2001;119:181-184.
20. Seemungal TA, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive disease. Am J Respir Crit Care Med. 2001;164: 1618-1623.
21. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283(4):499-505.
22. Greenberg SB, Cadena A, Lin J, et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:167-173.
23. Lieberman D, Lieberman D, Yaakov BM, et al. Infectious etiologies in acute exacerbations of COPD. Diagn Microbiol Infect Dis. 2001;40: 95-102.
24. Beaty CD, Grayston JT, Wang SP. Chlamydia pneumoniae, strain TWAR, infections in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991;16:1408-1410.
25. Klaus FR, Leonardo MF, Vogelmeier C, et al. Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotro-pium in COPD trial. Chest. 2013;143:711-719.
26. Wilson R. A vicious circle hypothesis operating during infective exacerbations of chronic bronchitis. Monaldi Arch Chest Dis. 1994;49: 159-164.
27. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Broncopneumol. 2012;48:86-98.
28. Sethi S, Mallia P, Johnston SL. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc Am Thorac Soc. 2009;6: 532-534.